Sun Pharma, Taro Pharmaceutical reach $75M settlement agreement in alleged price fixing scheme
The Indian multinational drugmaker Sun Pharma, alongside Israel’s Taro Pharmaceutical Industries, is cashing out tens of millions to settle a lawsuit in a US federal court.
In a motion dated Thursday, federal judge Cynthia M. Rufe out of Pennsylvania’s eastern district signed off on a settlement that would resolve antitrust litigation involving Sun Pharma and Taro Pharmaceuticals. The eight-page order detailed that the value was set for $75 million, with the chance for another $20 million to be added based on specific clauses in the settlement agreement.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters